Australia's largest stock trading and investment forum Australia's #1 stock forum

PAR

5.00%

19.0¢ paradigm biopharmaceuticals limited..

Do you have a link to that patent?

First 52 Last

Share
Profile

Follow
slura

3,791 Posts.

1554

13/10/21

15:14

Post #: 56770489
Share

Originally posted by iken2950: ↑

Arthropharm has an internationally published PPS patent: PCT/AU2021/050215, priority date 12 March 2020 which appears to comprehensively cover the treatment and prevention of acute respiratory distress syndrome (ARDS). The patent’s primary focus seems to be coronavirus, but it also includes “graft versus host disease (GVHD), avian influenza, smallpox, pandemic influenza, adult respiratory distress syndrome (ARDS), severe acute respiratory syndrome (SARS), sepsis, and systemic inflammatory response syndrome (SIRS). Their patent includes “any embodiment of the invention, the sulphated polysaccharide, preferably pentosan polysulfate (PPS) administered to the individual intravenously, subcutaneously, orally, intramuscularly, via gastric tube, intranasally or by inhalation”. PAR’s ASX announcement of encouraging results of its “preclinical proof-of-concept model of acute respiratory distress syndrome (ARDS)” suggests PPS may be a useful prevention or treatment, but if publication of the proof-of-concept study captures the interest of pharma, my guess is Arthropharm would be pharma’s first port of call, particularly as Arthropharm already markets PPS (Elmiron) and (Cartrophen). Has PR accidentally done them a favour? Better to keep focussed on getting the OA PPS CT approved and launched.

Expand

Do you have a link to that patent?

PAR Price at posting: $1.89 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

The winners & losers on market if negative gearing were gone

The market's shrugged at China's stimulus measures all year. Why is this one different?

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ZER

Zeta Resources seeks to resolve the Panoramic takeover story

NAM

ACCC seeks Olam divestments before its acquisition of Namoi Cotton can go ahead

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

4DX

4DMedical lands Philips US reseller deal with eye to Veterans Affairs' market post-lung damage

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

There are more pages in this discussion • 29 more messages in this thread...

First 52 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 19.0¢		Change -0.010(5.00%)		Mkt cap ! $66.54M

Open	High	Low	Value	Volume
20.0¢	21.0¢	19.0¢	$203.4K	1.019M

Buyers (Bids)

No.	Vol.	Price($)
14	387930	19.0¢

Sellers (Offers)

Price($)	Vol.	No.
20.5¢	65468	2

View Market Depth

No.	Vol.	Price($)
14	387930	0.190
3	57000	0.185
10	205428	0.180
6	140904	0.175
8	615605	0.170

Price($)	Vol.	No.
0.205	65468	2
0.210	28079	4
0.215	30000	1
0.220	27066	4
0.225	21604	2

Last trade - 16.10pm 27/09/2024 (20 minute delay)

PAR (ASX) Chart

Do you have a link to that patent?

The winners & losers on market if negative gearing were gone

The market's shrugged at China's stimulus measures all year. Why is this one different?

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Zeta Resources seeks to resolve the Panoramic takeover story

ACCC seeks Olam divestments before its acquisition of Namoi Cotton can go ahead

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

4DMedical lands Philips US reseller deal with eye to Veterans Affairs' market post-lung damage

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Do you have a link to that patent?

Top Stories

The winners & losers on market if negative gearing were gone

The market's shrugged at China's stimulus measures all year. Why is this one different?

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Zeta Resources seeks to resolve the Panoramic takeover story

ACCC seeks Olam divestments before its acquisition of Namoi Cotton can go ahead

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

4DMedical lands Philips US reseller deal with eye to Veterans Affairs' market post-lung damage

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News